CellSource Co (TSE:4880) Additional Paid-In Capital : 円1,336 Mil(As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Additional Paid-In Capital?

CellSource Co's quarterly additional paid-in capital increased from Jul. 2023 (円604 Mil) to Oct. 2023 (円1,335 Mil) and increased from Oct. 2023 (円1,335 Mil) to Jan. 2024 (円1,336 Mil).

CellSource Co's annual additional paid-in capital increased from Oct. 2021 (円589 Mil) to Oct. 2022 (円599 Mil) and increased from Oct. 2022 (円599 Mil) to Oct. 2023 (円1,335 Mil).

CellSource Co Additional Paid-In Capital Historical Data

The historical data trend for CellSource Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Additional Paid-In Capital Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Additional Paid-In Capital

Get a 7-Day Free Trial

503.42

582.82

589.12

599.23

1,335.40

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Additional Paid-In Capital	Get a 7-Day Free Trial															600.88	600.88	604.12	1,335.40	1,336.47

CellSource Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

CellSource Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CellSource Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines